SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Reata Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – RETA

NEW YORK, Oct. 31, 2020 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Reata Pharmaceuticals, Inc. (“Reata” or the “Company”) (NASDAQ: RETA) and certain of its officers. The class action, filed in United States District Court for the Eastern…

About the Author

has written 20652 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com